2019
DOI: 10.1016/j.path.2019.08.009
|View full text |Cite
|
Sign up to set email alerts
|

A Guide to Pheochromocytomas and Paragangliomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
26
1
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(30 citation statements)
references
References 85 publications
2
26
1
1
Order By: Relevance
“…PGLs have a higher frequency of metastasis than PCC. Retroperitoneal PGLs are more aggressive, metastasizing in up to 42% of cases [25].…”
Section: Discussionmentioning
confidence: 99%
“…PGLs have a higher frequency of metastasis than PCC. Retroperitoneal PGLs are more aggressive, metastasizing in up to 42% of cases [25].…”
Section: Discussionmentioning
confidence: 99%
“…In the other hand, the revised WHO classification no longer distinguishes benign or malignant tumors and that they all should be considered to contain some malignant potential which will only be revealed through metastasis [ 11 ] but the PASS predicted benign pheochromocytoma with a score < 4 and suggested a close follow up when PASS score’s exceeds 4 [ 12 ]…”
Section: Discussionmentioning
confidence: 99%
“…FNA of pheochromocytoma, when clinically suspected, is generally avoided due to adverse effects. Both pheochromocytoma and its extra adrenal counterpart paraganglioma are composed of cells that show positivity for neuroendocrine markers; however, they are negative for keratin 242 …”
Section: Immunocytochemistry For Genitourinary System and The Adrenal Gland Cytologymentioning
confidence: 99%